false
OasisLMS
Login
Catalog
SHM Converge Scientific Abstract ePoster Gallery
Massive Hemoptysis Following Covid-19 Infection
Massive Hemoptysis Following Covid-19 Infection
Back to course
Pdf Summary
A 65-year-old woman developed 7 days of fatigue, cough, and hemoptysis seven weeks after hospitalization for COVID-19 pneumonia treated with high-flow oxygen, remdesivir, dexamethasone, and tocilizumab. Her past history included hypertension, obesity, diabetes type 2, dislipidemia, and multinodular goiter. She was a former smoker with no history of tuberculosis, trauma, vasculitis, or recent travel.<br /><br />The case highlights a rare but serious complication of COVID-19: pulmonary artery pseudoaneurysm (PAP). PAP is an abnormal focal dilation involving the outer layers of the pulmonary artery wall and can cause life-threatening hemoptysis. Because prior imaging before her COVID-19 admission had been negative, the pseudoaneurysm was considered an acquired lesion likely associated with her recent SARS-CoV-2 infection.<br /><br />The authors note that COVID-19 can cause diffuse alveolar damage and vasculopathy, which may contribute to vascular complications such as PAP. Although the exact mechanism is not yet known, this case adds to growing evidence that post-COVID lung findings, including new nodules or focal consolidations, should prompt consideration of PAP even in the absence of symptoms.<br /><br />The key clinical message is that prompt recognition of pulmonary artery pseudoaneurysm after COVID-19 is essential to prevent massive, potentially fatal hemoptysis and to guide appropriate treatment.
Asset Subtitle
Lissette Orozco-Bersoza
Meta Tag
Author List
Elizabeth Henley, John Hopper, Lissette Orozco-Bersoza
Category
Clinical Vignettes
Concept
Pulmonary Artery Pseudoaneurysm
Concept
Hemoptysis
Concept
COVID-19 Infection
Distinguished
Non-Finalist
Presenter Organization
Trinity Health Ann Arbor Hospital
Presenting Author
Lissette Orozco-Bersoza
Track
Adult
Keywords
COVID-19
pulmonary artery pseudoaneurysm
hemoptysis
post-COVID complication
SARS-CoV-2
pulmonary vasculopathy
diffuse alveolar damage
lung nodule
focal consolidation
massive hemoptysis
Pulmonary Artery Pseudoaneurysm
Hemoptysis
COVID-19 Infection
×
Please select your language
1
English